Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area

European Respiratory Journal

Volumn 23, Issue 3, 2004, Pages 446-451

  Rajalahti, Iiris ^a   Ruokonen, E L ^c   Kotomaki T ^d   Sintonen, H ^d   Nieminen, M M ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cost effectiveness; Diagnosis; Polymerase chain reaction test; Pulmonary tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECONOMIC EVALUATION; HEALTH CARE COST; HUMAN; INCIDENCE; LABORATORY TEST; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; MYCOBACTERIUM; PATIENT CARE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SPUTUM SMEAR; TREATMENT PLANNING;

COST-BENEFIT ANALYSIS; DECISION TREES; FINLAND; HEALTH CARE COSTS; HUMANS; INCIDENCE; POLYMERASE CHAIN REACTION; PREVALENCE; SPECIMEN HANDLING; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 1542504657     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.04.00009704     Document Type: Article

References (14)

1. Rao VK, Iademarco EP, Fraser VJ, Kollef MH. Delays in the suspicion and treatment of tuberculosis among hospitalized patients. Ann Intern Med 1999; 130: 404-411.
2. Mathur P, Sacks L, Auten G, Sall R, Levy C, Gordin F. Delayed diagnosis of pulmonary tuberculosis in city hospitals. Arch Intern Med 1994; 154: 306-310.
3. Pfyffer GE, Welscher H-M, Kissling P, et al. Comparison of the mycobacteria growth indicator tube (MGIT) with radiometric and solid culture for recovery of acid-fast bacilli. J Clin Microbiol 1997; 35: 364-368.
4. Gamboa F, Fernandez G, Padilla E, et al. Comparative evaluation of initial and new versions of the Gen-Probe amplified Mycobacterium tuberculosis direct test for direct detection of Mycobacterium tuberculosis in respiratory and nonrespiratory specimens. J Clin Microbiol 1998; 36: 684-689.
5. Ichiyama S, Iinuma Y, Tawada Y, et al. Evaluation of Gen-Probe amplified Mycobacterium tuberculosis direct test and Roche PCR-microwell plate hybridization method (AMPLICOR MYCOBACTERIUM) for direct detection of mycobacteria. J Clin Microbiol 1996; 34: 130-133.
6. Rajalahti I, Vuorinen P, Nieminen MM, Miettinen A. Detection of Mycobacterium tuberculosis complex in sputum specimens by the Automated Roche Cobas Amplicor Mycobacterium Tuberculosis test. J Clin Microbiol 1998; 36: 975-978.
7. Della-Latta P, Whittier S. Comprehensive evaluation of performance, laboratory application, and clinical usefulness of two direct amplification technologies for the detection of Mycobacterium tuberculosis complex. Am J Clin Pathol 1998; 110: 301-310.
8. Härö AS. Long-term evaluation of mass BCG-vaccination campaign: A study of 30 years of experience in Finland. In: Tuberculosis and Respiratory Diseases. Helsinki, Year book of Finnish Anti-tuberculosis Association, 1977; p. 6.
9. Flanagan PG, Williams R, Paull A. Comparison of two automated systems for the isolation of mycobacteria from clinical specimens. Eur J Clin Microbiol Infect Dis 1999; 18: 912-914.
10. Scarparo C, Piccoli P, Rigon A, Ruggiero G, Scagnelli M, Piersimoni C. Comparison of enhanced Mycobacterium tuberculosis amplified direct test with COBAS AMPLICOR Mycobacterium tuberculosis assay for direct detection of Mycobacterium tuberculosis complex in respiratory and extrapulmonary specimens. J Clin Microbiol 2000; 38: 1559-1562.
11. Nelson SM, Deike MA, Cartwright CP. Value of examining multiple specimens in the diagnosis of pulmonary tuberculosis. J Clin Microbiol 1998; 36: 467-469.
12. Divinagracia RM, Harkin TJ, Bonk S, Schluger NW. Screening by specialists to reduce unnecessary test ordering in patients evaluated for tuberculosis. Chest 1998; 114: 681-684.
13. Catanzaro A, Perry S, Clarridge JE, et al. The role of clinical suspicion in evaluating a new diagnostic test for active tuberculosis. JAMA 2000; 283: 639-645.
14. Wurtz R, White WD. The cost of tuberculosis: Utilization and estimated charges for the diagnosis and treatment of tuberculosis in a public health system. Int J Tuberc Lung Dis 1999; 3: 382-387.